Article
The French Blood Agency announces agreement with TreeFrog Therapeutics to scale-up manufacturing of iPS-derived hematopoietic stem cell transplants
…the past 6 years, we have tested our protocol with 5 iPSC lines and demonstrated full hematopoietic recovery in large-scale in vivo studies (N=400). Our iPSC-derived HSC transplants are now…